Quantum-Si (NASDAQ:QSI) Stock Gets Downgrade from Wall Street Zen

Key Points

• Wall Street Zen downgraded Quantum-Si from “hold” to “sell,” while the broader analyst consensus remains “Hold” with a $2.50 price target.
• Quantum-Si shares opened at $1.12, with a market capitalization of approximately $245 million and a 52-week trading range of $0.69 to $2.73.
• The company reported a quarterly loss of $0.11 per share and $0.34 million in revenue, while hedge funds and institutional investors own about 39.9% of its stock.

Quantum-Si (NASDAQ:QSI - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a research report issued to clients and investors on Monday, Wall Street Zen reports.

A number of other research firms have also recently issued reports on QSI. Weiss Ratings raised shares of Quantum-Si from a "sell (e+)" rating to a "sell (d-)" rating in a report on Thursday, September 24th. HC Wainwright set a $4.00 price objective on shares of Quantum-Si in a report on Friday, October 9th. Finally, Alliance Global Partners reissued a "buy" rating on shares of Quantum-Si in a research report on Friday, August 14th. Two investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat, Quantum-Si currently has a consensus rating of "Hold" and a consensus price target of $2.50.

Quantum-Si Stock Performance

Shares of NASDAQ QSI opened at $1.12 on Monday. The company has a market cap of $245.15 million, a PE ratio of -2.43 and a beta of 3.21. The business has a 50-day simple moving average of $0.92 and a two-hundred day simple moving average of $0.91. Quantum-Si has a fifty-two week low of $0.69 and a fifty-two week high of $2.73.

Quantum-Si (NASDAQ:QSI - Get Free Report) last posted its quarterly earnings data on Thursday, August 13th. The company reported ($0.11) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.11). The firm had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.30 million. Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. On average, sell-side analysts predict that Quantum-Si will post -0.47 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Quantum-Si

Several institutional investors have recently made changes to their positions in QSI. Renaissance Technologies LLC purchased a new position in Quantum-Si during the first quarter worth approximately $91,000. WINTON GROUP Ltd purchased a new position in shares of Quantum-Si in the second quarter worth about $67,000. Green Alpha Advisors LLC acquired a new position in Quantum-Si during the second quarter worth about $41,000. Corient Private Wealth LP purchased a new stake in Quantum-Si during the 2nd quarter valued at about $34,000. Finally, IPG Investment Advisors LLC purchased a new stake in Quantum-Si during the 2nd quarter valued at about $27,000. 39.90% of the stock is owned by hedge funds and other institutional investors.

Quantum-Si Company Profile

Quantum-Si Incorporated NASDAQ: QSI is a life sciences technology company focused on advancing proteomics, the study of proteins and their functions. The company develops tools intended to make protein analysis more accessible, scalable and cost-effective for researchers, pharmaceutical companies, biotechnology firms and academic institutions.

Its primary offering is the Platinum platform, which combines a benchtop protein sequencing instrument with single-use consumables and software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.